World's Best Scientists 2026 revealed!
Giuseppe Pelosi

Giuseppe Pelosi

D-Index & Metrics

Medicine

D-Index
80
Citations
27716
World Ranking
16987
National Ranking
680

Giuseppe Pelosi publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Giuseppe Pelosi sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 427 publications — 44th percentile

44% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Giuseppe Pelosi D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Giuseppe Pelosi sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 80 D-Index — 16th percentile

16% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Giuseppe Pelosi is affiliated with the University of Milan in Italy and has contributed extensively to the field of medicine, particularly focusing on pulmonary and respiratory medicine, oncology, and epidemiology. Their research includes a broad spectrum of studies related to lung cancer, neuroendocrine tumors, and medical imaging and pathology.

The scientist's recent publications include the following notable papers:

  • A Grading System for Invasive Pulmonary Adenocarcinoma: A Proposal From the International Association for the Study of Lung Cancer Pathology Committee, 2020, Journal of Thoracic Oncology
  • IASLC Multidisciplinary Recommendations for Pathologic Assessment of Lung Cancer Resection Specimens After Neoadjuvant Therapy, 2020, Journal of Thoracic Oncology
  • The Promises and Challenges of Tumor Mutation Burden as an Immunotherapy Biomarker: A Perspective from the International Association for the Study of Lung Cancer Pathology Committee, 2020, Journal of Thoracic Oncology
  • Recommendations for Implementing Lung Cancer Screening with Low-Dose Computed Tomography in Europe, 2020, Cancers
  • Morphologic and molecular classification of lung neuroendocrine neoplasms, 2021, Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin

Giuseppe Pelosi collaborates frequently with a group of coauthors who have contributed to multiple works together. These include:

  • Mauro Papotti
  • Sergio Harari
  • Paul Hofman
  • Fabrizio Bianchi
  • Véronique Hofman

The main publication venues where this researcher's work appears often are:

  • Journal of Thoracic Oncology
  • Pathologica
  • Expert Review of Anticancer Therapy
  • ESMO Open
  • Cancers

In terms of their fields of study, Giuseppe Pelosi has contributed 206 publications primarily in medicine. Their specific subfields of focus include:

  • Pulmonary and Respiratory Medicine (54 publications)
  • Oncology (54 publications)
  • Epidemiology (38 publications)
  • Neurology (29 publications)
  • Molecular Biology (12 publications)

Their research topics encompass several key areas:

  • Neuroendocrine Tumor Research Advances
  • Lung Cancer Research Studies
  • Neuroblastoma Research and Treatments
  • Lung Cancer Treatments and Mutations
  • Lung Cancer Diagnosis and Treatment
  • Medical Imaging and Pathology Studies
  • Gestational Trophoblastic Disease Studies

Best Publications

  • The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification

    William D. Travis;Elisabeth Brambilla;Andrew G. Nicholson;Yasushi Yatabe

  • Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids

    Martyn E. Caplin;E. Baudin;P. Ferolla;P. Filosso

  • Quantification of Free Circulating DNA As a Diagnostic Marker in Lung Cancer

    Gabriella Sozzi;Davide Conte;MariaElena Leon;Rosalia Cirincione

  • PD-L1 Immunohistochemistry Comparability Study in Real-Life Clinical Samples: Results of Blueprint Phase 2 Project.

    Ming Sound Tsao;Keith M. Kerr;Mark Kockx;Mary Beth Beasley

  • Early lung-cancer detection with spiral CT and positron emission tomography in heavy smokers: 2-year results.

    Ugo Pastorino;Massimo Bellomi;Claudio Landoni;Elvio De Fiori

  • Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial.

    Ugo Pastorino;Marta Rossi;Valentina Rosato;Alfonso Marchianò

  • Alterations of the Notch pathway in lung cancer

    Britta Westhoff;Ivan N. Colaluca;Giovanni D'Ario;Maddalena Donzelli

  • p40 (ΔNp63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma.

    Justin A Bishop;Julie Teruya-Feldstein;William H Westra;Giuseppe Pelosi

  • A serum circulating miRNA diagnostic test to identify asymptomatic high‐risk individuals with early stage lung cancer

    Fabrizio Bianchi;Francesco Nicassio;Matteo Jacopo Marzi;Elena Belloni

  • Clinical Response of Carcinomas Harboring the BRD4-NUT Oncoprotein to the Targeted Bromodomain Inhibitor OTX015/MK-8628

    Anastasios Stathis;Emanuele Zucca;Mohamed Bekradda;Carlos Gomez-Roca

  • Endocrine tumors of the pancreas: Ki-67 immunoreactivity on paraffin sections is an independent predictor for malignancy: A comparative study with proliferating-cell nuclear antigen and progesterone receptor protein immunostaining, mitotic index, and other clinicopathologic variables

    Giuseppe Pelosi;Enrica Bresaola;Giuseppe Bogina;Felice Pasini

  • A Grading System for Invasive Pulmonary Adenocarcinoma: A Proposal From the International Association for the Study of Lung Cancer Pathology Committee.

    Andre L. Moreira;Paolo S.S. Ocampo;Yuhe Xia;Hua Zhong

  • Best Practices Recommendations for Diagnostic Immunohistochemistry in Lung Cancer

    Yasushi Yatabe;Sanja Dacic;Alain C. Borczuk;Arne Warth

  • IASLC Multidisciplinary Recommendations for Pathologic Assessment of Lung Cancer Resection Specimens After Neoadjuvant Therapy.

    William D. Travis;Sanja Dacic;Ignacio Wistuba;Lynette Sholl

  • Typical and atypical pulmonary carcinoid tumor overdiagnosed as small-cell carcinoma on biopsy specimens: a major pitfall in the management of lung cancer patients.

    Giuseppe Pelosi;Jaime Rodriguez;Giuseppe Viale;Juan Rosai

  • Reproducibility of histopathological subtypes and invasion in pulmonary adenocarcinoma. An international interobserver study

    Erik Thunnissen;Mary Beth Beasley;Alain C. Borczuk;Elisabeth Brambilla

  • A randomized trial of low-dose tamoxifen on breast cancer proliferation and blood estrogenic biomarkers.

    Andrea Decensi;Chris Robertson;Giuseppe Viale;Francesca Pigatto

  • PD-L1 Testing for Lung Cancer in 2019 : Perspective From the IASLC Pathology Committee

    Sylvie Lantuejoul;Ming Sound-Tsao;Wendy A. Cooper;Nicolas Girard

  • The Promises and Challenges of Tumor Mutation Burden as an Immunotherapy Biomarker: A Perspective from the International Association for the Study of Lung Cancer Pathology Committee

    Lynette M. Sholl;Fred R. Hirsch;David Hwang;Johan Botling

  • O-297 Quantification of free circulating DNA as a diagnostic marker in lung cancer

    Gabriella Sozzi;Davide Conte;Maria Elena Leon;Rosalia Cirincione

Frequent Co-Authors

Giuseppe Viale
Giuseppe Viale University of Milan
Mauro Papotti
Mauro Papotti University of Turin
Patrick Maisonneuve
Patrick Maisonneuve European Institute of Oncology
Filippo de Braud
Filippo de Braud University of Milan
Ugo Pastorino
Ugo Pastorino University of Milan
Gabriella Sozzi
Gabriella Sozzi University of Milan
William D. Travis
William D. Travis Memorial Sloan Kettering Cancer Center
Andrew G. Nicholson
Andrew G. Nicholson Royal Brompton Hospital
Keith M. Kerr
Keith M. Kerr Aberdeen Royal Infirmary
Yasushi Yatabe
Yasushi Yatabe Nagoya University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in medicine opens the door to diverse opportunities in the expanding healthcare industry. For those interested in healthcare leadership and administration, online mha programs are a flexible way to gain advanced management skills tailored to healthcare settings.

If you are looking to specialize in nutrition, an online bachelor's in nutrition allows you to study key concepts in nutritional science and dietetics—often leading to roles in wellness, health consulting, or food service management.

Nursing professionals seeking to advance their credentials may benefit from rn bsn online programs no clinicals, enabling registered nurses to earn a Bachelor of Science in Nursing entirely online, often without the need for additional on-site clinical hours.

For those aiming for the highest level of nursing practice, dnp online programs provide a pathway to a Doctor of Nursing Practice, typically with flexible and accelerated formats.

These varied online programs offer accessible routes to enter or advance within healthcare, leveraging technology for a more adaptable learning experience.

Best Scientists Citing Giuseppe Pelosi

Trending Scientists

Recently Published Articles